Group One Trading’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.9M | Buy |
784,600
+40,800
| +5% | +$1.9M | 0.08% | 244 |
|
|
2025
Q4 | $21.9M | Buy |
743,800
+106,500
| +17% | +$2.89M | 0.04% | 492 |
|
|
2025
Q3 | $16.5M | Buy |
637,300
+211,400
| +50% | +$5.9M | 0.03% | 589 |
|
|
2025
Q2 | $11.8M | Sell |
425,900
-121,100
| -22% | -$3.19M | 0.03% | 708 |
|
|
2025
Q1 | $15.5M | Buy |
547,000
+293,200
| +116% | +$10.4M | 0.05% | 414 |
|
|
2024
Q4 | $10.6M | Buy |
253,800
+130,000
| +105% | +$6.21M | 0.02% | 667 |
|
|
2024
Q3 | $8.27M | Buy |
123,800
+39,300
| +47% | +$3.61M | 0.02% | 709 |
|
|
2024
Q2 | $10M | Buy |
84,500
+8,900
| +12% | +$1.13M | 0.04% | 445 |
|
|
2024
Q1 | $8.06M | Sell |
75,600
-128,500
| -63% | -$13M | 0.03% | 545 |
|
|
2023
Q4 | $20.3M | Buy |
204,100
+70,100
| +52% | +$5.9M | 0.05% | 343 |
|
|
2023
Q3 | $13.8M | Buy |
134,000
+24,800
| +23% | +$2.77M | 0.05% | 360 |
|
|
2023
Q2 | $13.3M | Sell |
109,200
-17,800
| -14% | -$2.37M | 0.04% | 383 |
|
|
2023
Q1 | $19.5M | Sell |
127,000
-1,044,000
| -89% | -$172M | 0.07% | 218 |
|
|
2022
Q4 | $210M | Buy |
1,171,000
+143,900
| +14% | +$23.5M | 0.49% | 18 |
|
|
2022
Q3 | $121M | Sell |
1,027,100
-748,400
| -42% | -$114M | 0.24% | 41 |
|
|
2022
Q2 | $254M | Sell |
1,775,500
-224,600
| -11% | -$32.1M | 0.4% | 22 |
|
|
2022
Q1 | $345M | Buy |
2,000,100
+164,300
| +9% | +$27.7M | 0.34% | 25 |
|
|
2021
Q4 | $466M | Buy |
1,835,800
+283,700
| +18% | +$82.9M | 0.37% | 25 |
|
|
2021
Q3 | $597M | Buy |
1,552,100
+792,400
| +104% | +$292M | 0.65% | 13 |
|
|
2021
Q2 | $179M | Buy |
759,700
+232,700
| +44% | +$41.6M | 0.22% | 53 |
|
|
2021
Q1 | $69M | Sell |
527,000
-355,300
| -40% | -$51.5M | 0.1% | 148 |
|
|
2020
Q4 | $92.2M | Buy |
882,300
+204,300
| +30% | +$20.7M | 0.16% | 74 |
|
|
2020
Q3 | $48M | Buy |
678,000
+231,000
| +52% | +$16.1M | 0.15% | 99 |
|
|
2020
Q2 | $28.7M | Sell |
447,000
-120,100
| -21% | -$6.58M | 0.13% | 137 |
|
|
2020
Q1 | $17M | Buy |
567,100
+231,400
| +69% | +$5.32M | 0.14% | 135 |
|
|
2019
Q4 | $6.57M | Buy |
335,700
+230,700
| +220% | +$4.09M | 0.04% | 526 |
|
|
2019
Q3 | $1.67M | Buy |
105,000
+13,400
| +15% | +$198K | 0.01% | 1343 |
|
|
2019
Q2 | $1.34M | Buy |
91,600
+75,000
| +452% | +$1.61M | 0.01% | 1381 |
|
|
2019
Q1 | $338K | Buy |
16,600
+15,200
| +1,086% | +$282K | ﹤0.01% | 2263 |
|
|
2018
Q4 | $21K | Buy |
+1,400
| New | +$23K | ﹤0.01% | 4004 |
|
Other funds holding MRNA
VCM
VPM
Group One Trading's MRNA Position: Q1 2026 in Review
Group One Trading reduced its Moderna (MRNA) stake by 75% in Q1 2026, selling an estimated $6.63M and leaving 47,901 shares worth $2.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1902.
Group One Trading first reported a position in MRNA in Q4 2018 and has held it in 25 quarters since. The position peaked at $37.3M in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.
- Group One Trading held 47,901 shares of Moderna worth $2.43M as of Q1 2026.
- Group One Trading sold 142,054 Moderna shares in Q1 2026, an estimated $6.63M.
- Moderna made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #1902 holding.
- Group One Trading first reported a position in Moderna in Q4 2018 and has held it in 25 quarters since.
- Group One Trading's Moderna position peaked at $37.3M in Q4 2022.
- 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.